Mirus(美國(guó))

Roche Mirus

美國(guó)MirusBio www.mirusbio.comMirusBio公司是RNA干擾和基因治療領(lǐng)域的者。該公司的DynamicPolyConjugates技術(shù)改良后能成為siRNA療法的平臺(tái)。在基因治療方面，該公司通過(guò)專(zhuān)利的PathwayIVhydro-dynamicdelivery平臺(tái)開(kāi)發(fā)了全新的人類(lèi)療法。主要項(xiàng)目是與TransgeneS.A.合作開(kāi)發(fā)的肌肉萎縮癥治療。另外，Mirus還推出了 的DNA和siRNA轉(zhuǎn)染、標(biāo)記產(chǎn)品。2008年羅氏以1.25億美元收購(gòu)RNAi和基因治療公司Mirus CorporateOverviewMirusBioLLCisalifesciencecompanyfocusedondiscovering,developingandcommercializinginnovativenucleicacidbasedtechnologiesandproducts.MirusR&Duniquelyintegratesnucleicaciddeliveryandchemistry,acorecompetencywhichisunmatchedintheindustry.Thisservesasthefoundationforitsnovelresearchreagents.RESEARCHREAGENTSMirusisarecognizedleaderindevelopinginnovativenucleicacidresearchreagents,distinguishedbyitsmanyaccomplishments:FirsttodevelopansiRNAtransfectionreagent(2001)Pioneereddevelopmentofhighefficiency/lowtoxicitytransfection